17-81239949-C-T

Variant summary

Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong

The NM_001353403.1(NDUFAF8):​c.37+6C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000729 in 536,514 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.00061 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00078 ( 0 hom. )

Consequence

NDUFAF8
NM_001353403.1 splice_region, intron

Scores

2

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:8

Conservation

PhyloP100: -0.0100
Variant links:
Genes affected
NDUFAF8 (HGNC:33551): (NADH:ubiquinone oxidoreductase complex assembly factor 8) Involved in mitochondrial respiratory chain complex I assembly. Located in mitochondrion. Implicated in nuclear type mitochondrial complex I deficiency 34. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 10 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-81239949-C-T is Pathogenic according to our data. Variant chr17-81239949-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 691642.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-81239949-C-T is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NDUFAF8NM_001086521.2 linkc.195+271C>T intron_variant Intron 2 of 2 ENST00000431388.3 NP_001079990.1 A1L188
NDUFAF8NM_001353402.1 linkc.199+267C>T intron_variant Intron 2 of 2 NP_001340331.1
NDUFAF8NM_001353403.1 linkc.37+6C>T splice_region_variant, intron_variant Intron 2 of 2 NP_001340332.1
NDUFAF8NR_148426.1 linkn.36C>T non_coding_transcript_exon_variant Exon 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NDUFAF8ENST00000431388.3 linkc.195+271C>T intron_variant Intron 2 of 2 1 NM_001086521.2 ENSP00000400184.2 A1L188

Frequencies

GnomAD3 genomes
AF:
0.000611
AC:
93
AN:
152220
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00121
Gnomad OTH
AF:
0.000955
GnomAD4 exome
AF:
0.000775
AC:
298
AN:
384294
Hom.:
0
Cov.:
3
AF XY:
0.000863
AC XY:
175
AN XY:
202684
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000677
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000740
Gnomad4 NFE exome
AF:
0.00104
Gnomad4 OTH exome
AF:
0.00160
GnomAD4 genome
AF:
0.000611
AC:
93
AN:
152220
Hom.:
0
Cov.:
32
AF XY:
0.000457
AC XY:
34
AN XY:
74370
show subpopulations
Gnomad4 AFR
AF:
0.000145
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000188
Gnomad4 NFE
AF:
0.00121
Gnomad4 OTH
AF:
0.000955
Alfa
AF:
0.000953
Hom.:
0
Bravo
AF:
0.000601

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Mitochondrial complex 1 deficiency, nuclear type 34 Pathogenic:5
Mar 30, 2022
Undiagnosed Diseases Network, NIH
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 30, 2022
Baylor Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 07, 2020
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Feb 02, 2022
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Likely pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with mitochondrial complex I deficiency, nuclear type 34 (MIM#618776). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0209 - Splice site variant proven to affect splicing of the transcript with uncertain effect on protein sequence. Functional analysis of patient fibroblasts shows this variant results in intron retention and the loss of isoform 2. However, the exact protein outcome is unclear as this would be expected to result in a truncated protein (PMID: 31866046). (SP) 0252 - This variant is homozygous. (I) 0304 - Variant is present in gnomAD (v3) <0.01 for a recessive condition (93 heterozygotes, 0 homozygotes). (SP) 0705 - No comparable intronic variants have previous evidence for pathogenicity. (I) 0802 - This variant has moderate previous evidence of pathogenicity in unrelated individuals. This variant has been described as likely pathogenic and pathogenic, and observed in two unrelated compound heterozygous individuals with Leigh syndrome and complex I deficiency (ClinVar, PMID: 31866046). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -

May 21, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: C17ORF89 (NDUFAF8) c.195+271C>T is located at a position not widely known to affect splicing. However, several computational tools predict a significant impact on normal splicing: Three predict the variant strengthens a cryptic intronic 5 donor site. Experimental evidence demonstrated this variant was associated with an mRNA defect leading to loss of the functionally relevant transcript (Alston_2020). The variant allele was found at a frequency of 0.00062 in 150992 control chromosomes, predominantly at a frequency of 0.0012 within the Non-Finnish European subpopulation in the gnomAD v3.1.1 database. Due to an unknown prevalence of C17ORF89 associated Mitochondrial Complex 1 Deficiency, this frequency relative to that expected for a pathogenic variant in C17ORF89 is unknown, allowing no conclusion about variant significance. c.195+271C>T has been reported in the literature in two comprehensively genotyped compound heterozygous individuals affected with Mitochondrial Complex 1 Deficiency (Alston_2020). Experimental evidence derived from studies on fibroblasts and muscle cells from one of these individuals indicated a decrease in complex I activity, a reduction in oxidative capacity, decreased levels of fully assembled complex I and a generalized reduction in complex I subunits (Alston_2020). These data indicate that the variant may be associated with disease. Two ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -

NDUFAF8-related disorder Pathogenic:1
Jun 06, 2024
PreventionGenetics, part of Exact Sciences
Significance: Likely pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

The NDUFAF8 c.199+267C>T variant is predicted to interfere with splicing. This variant, also reported as c.195+271C>T in transcript NM_001086521, has been reported in two unrelated individuals with a clinical diagnosis of Leigh syndrome (subjects 1 and 2, Alston et al. 2019. PubMed ID: 31866046). In vitro studies from subject 1's fibroblast cells demonstrated expression of this variant results in aberrant splicing, a reduction in oxidative capacity, as well as decreased levels of fully assembled complex I in both muscle cells and fibroblasts compared to controls (Figures S3, S4 and 3, Alston et al. 2019. PubMed ID: 31866046). Additionally, a rescue assay demonstrated that this phenotype could be corrected by a reintroduction of wildtype (Figure 3, Alston et al. 2019. PubMed ID: 31866046). This variant is reported in 0.12% of alleles in individuals of European (non-Finnish) descent in gnomAD. This variant is interpreted as likely pathogenic. -

Mitochondrial disease Pathogenic:1
Oct 09, 2019
Wellcome Centre for Mitochondrial Research, Newcastle University
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Pathogenic:1
Aug 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

NDUFAF8: PM3:Strong, PM2, PS3:Supporting -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
2.5
DANN
Benign
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.28
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.28
Position offset: -6

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs745332456; hg19: chr17-79213749; API